Skip to main content
. 2024 Jan 9;17(1):100853. doi: 10.1016/j.waojou.2023.100853

Table 4.

Associations of Elaeis guineensis (oil palm) pollen sensitization with the severity and frequency of symptoms of allergic diseases among house dust mite-sensitized individuals in the Singapore/Malaysia Chinese population.

HDM-sensitized individuals (n = 8089)


Elaeis guineensis
Positive SPT
Elaeis guineensis
Negative SPT
P-value OR (95% CI)
Case/Control (%Case) Case/Control (%Case)
Asthma-related symptomsa
Wheezing 39/107 (26.7) 261/1182 (18.1) 0.0116 1.67 (1.11–2.46)
Wheezing with exercise 26/120 (17.8) 180/1263 (12.5) 0.0581 1.55 (0.97–2.41)
Nocturnal cough 41/105 (28.1) 286/1157 (19.8) 0.0150 1.62 (1.09–2.36)
Asthma-related exacerbationsa
Daytime Asthma Attack 34/112 (23.3) 189/1254 (13.1) 0.00107 2.02 (1.31–3.04)
Nighttime Asthma Attack 36/110 (24.7) 162/1281 (11.2) 5.38 x 106 2.64 (1.72–3.98)
School Absence 6/140 (4.1) 73/1370 (5.1) 0.389 0.66 (0.24–1.57)
GP/Specialist Visits 31/115 (21.2) 172/1271 (11.9) 0.00207 2.08 (1.29–3.27)
A&E Admission 7/139 (4.8) 45/1398 (3.1) 0.428 1.43 (0.54–3.31)
Hospitalization 5/141 (3.4) 15/1428 (1) 0.0305 3.22 (1.01–8.77)
Any Exacerbation Eventb 32/114 (21.9) 183/1260 (12.7) 0.00256 2.03 (1.27–3.19)
AR-related symptomsc
Itchy nose 239/54 (81.6) 2361/702 (77.1) 0.0415 1.38 (1.02–1.89)
Sneezing 268/27 (90.8) 2801/269 (91.2) 0.933 0.98 (0.66–1.52)
Runny nose 249/47 (84.1) 2634/426 (86.1) 0.293 0.84 (0.61–1.18)
Nose blockage 240/55 (81.4) 2493/563 (81.6) 0.647 0.93 (0.69–1.28)
Severity of AR symptomsd
Mild, n (%) 73 (24.7) 1022 (33.2)
Moderate-to-severe, n (%) 223 (75.3) 2053 (66.8) 0.00266 1.53 (1.16–2.02)

A&E: accident and emergency department of a hospital; AR: allergic rhinitis; CI: confidence interval; GP: general practitioner; HDM: house dust mite; OR: odds ratio; SPT: skin prick test. All data were evaluated based on skin prick test results of the Elaeis guineensis (oil palm) pollen allergen in a cross-sectional cohort of Singapore/Malaysia Chinese individuals with positive sensitization to house dust mite allergens (n = 8089). P-value, odds ratio, and 95% CI were calculated using a logistic regression analysis with adjustment for age and gender.

p < 0.05 is considered as significant.

a

Asthma-related symptoms and exacerbation: cases are defined as asthma-affected individuals with the presence of asthma-related symptoms or exacerbations in the past 12 months. Controls are defined as asthma-affected individual with the absence of respective symptoms or exacerbations in the past 12 months.

b

Any exacerbation event includes school absence, GP/specialist visits, A&E admission, or hospitalization due to asthma exacerbation.

c

AR-related symptoms: cases are defined as AR-affected individuals with the presence of AR-related symptoms or exacerbations in the past 12 months. Controls are defined as AR-affected individual with the absence of respective symptoms in the past 12 months.

d

Severity of AR symptoms: Moderate-to-severe AR was defined as AR-affected individuals having at least one of the following disturbances due to AR-related symptoms in the past 12 months: disturbed sleep, impaired daily activities including sport, leisure, impaired work and school, and troublesome symptoms. Mild AR was defined as AR-affected individuals with the absence of these disturbances